Scholars Central

ArticlePublished 2014

High-Dose Corticosteroid Therapy for Erlotinib-Induced Interstitial Lung Disease in Japanese Patient with Advanced Pancreatic Cancer

Authors: Masato Yoshioka, Go Watanabe, Hiroshi Uchinami, Norihito Ise, Yasuhiko Nakagawa, Kazuhiro Kudoh, Ryo Morita, Hideaki Andoh, Yuzo Yamamoto

Journal of the Pancreas

Volume 15 · Issue 6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Context Erlotinib is a selective epidermal growth factor receptor tyrosine kinase inhibitor used as a target therapy against non-small lung cancer and advanced pancreatic cancer. A regimen of erlotinib plus gemcitabine has been proven to prolong overall survival in the patient with advanced pancreatic cancer. In addition to common adverse effects, such as diarrhea, mucositis and skin rash (acne form eruptions), acute interstitial lung disease (ILD) has been reported as an infrequent but potentially fatal complication. We here report a case of a Japanese patient with erlotinib-induced ILD in whom high-dose corticosteroid therapy was successful. Case report A fifty five-year-old male with cancer of the head of the pancreas with multiple liver metastases started treatment with gemcitabine plus erlotinib. On the 13th day of erlotinib treatment, he had high fever. Chest computed tomography (CT) scan showed a diffuse ground-glass like infiltration of bothlungs. He was diagnosed with ILD, and high-dose corticosteroid therapy was started. Two weeks after the introduction of steroid therapy, the reticular shadow faded away on CT. He was successfully treated with corticosteroid for erlotinib-induced acute ILD although he died 6 months after the initiation of chemotherapy owing to disease progression. Conclusion we showed a case of a successfully treated Japanese patient of erlotinib-induced ILD. Because erlotinib-induced ILD would frequently occur in Japanese patients, closer attention to ILD should be paid for Japanese patients than in Western populations. If erlotinib-induced ILD occurs, a high-dose corticosteroid therapy would be a useful option of treatment.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of the Pancreas.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of the Pancreas
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Masato Yoshioka”
  • BylineArticles whose byline prints “Go Watanabe”
  • BylineArticles whose byline prints “Hiroshi Uchinami”
  • BylineArticles whose byline prints “Norihito Ise”
  • BylineArticles whose byline prints “Yasuhiko Nakagawa”
  • BylineArticles whose byline prints “Kazuhiro Kudoh”
  • BylineArticles whose byline prints “Ryo Morita”
  • BylineArticles whose byline prints “Hideaki Andoh”